Crossing-over to imatinib 800 mg in a patient with GIST, after progression with standard dosage: a case report

A 69-years-old patient underwent radical surgery to remove a lesion of small bowel with histological diagnosis of malignant primary stromal cancer of the gastro-intestinal wall (GIST). After a disease-free survival of 25 months instrumental evidence of loco-regional recurrence was detected with subs...

Full description

Bibliographic Details
Main Authors: Giuseppe Naso, Enrico Cortesi
Format: Article
Language:English
Published: SEEd 2015-10-01
Series:Clinical Management Issues
Subjects:
Online Access:https://journals.seedmedicalpublishers.com/index.php/cmi/article/view/1103